Your browser doesn't support javascript.
loading
SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma.
Suzuki, Koya; Tange, Masaki; Yamagishi, Ryota; Hanada, Hiroyuki; Mukai, Satomi; Sato, Tatsuhiro; Tanaka, Takeshi; Akashi, Tomohiro; Kadomatsu, Kenji; Maeda, Tohru; Miida, Takashi; Takeuchi, Ichiro; Murakami, Hiroshi; Sekido, Yoshitaka; Murakami-Tonami, Yuko.
Afiliación
  • Suzuki K; Department of Clinical Laboratory of Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Tange M; Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Yamagishi R; Cancer Molecular Genetics Lab, Tokyo University of Technology Graduate School of Bionics, Tokyo, Japan.
  • Hanada H; Advanced Comprehensive Research Organization, Teikyo University, Tokyo, Japan.
  • Mukai S; Cancer Molecular Genetics Lab, Tokyo University of Technology Graduate School of Bionics, Tokyo, Japan.
  • Sato T; Department of Pathophysiology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Tanaka T; Center for Advanced Intelligence Project, RIKEN, Tokyo, Japan.
  • Akashi T; Division of Cancer Biology, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Kadomatsu K; Division of Cancer Biology, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Maeda T; Interprotein Corporation, Sagamihara, Japan.
  • Miida T; Department of Integrative Cellular Informatics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Takeuchi I; Department of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Murakami H; Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan.
  • Sekido Y; College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan.
  • Murakami-Tonami Y; Department of Clinical Laboratory of Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Cell Death Discov ; 8(1): 446, 2022 Nov 05.
Article en En | MEDLINE | ID: mdl-36335095
ABSTRACT
Many genes responsible for Malignant mesothelioma (MM) have been identified as tumor suppressor genes and it is difficult to target these genes directly at a molecular level. We searched for the gene which showed synthetic lethal phenotype with LATS2, one of the MM causative genes and one of the kinases in the Hippo pathway. Here we showed that knockdown of SMG6 results in synthetic lethality in LATS2-inactivated cells. We found that this synthetic lethality required the nuclear translocation of YAP1 and TAZ. Both are downstream factors of the Hippo pathway. We also demonstrated that this synthetic lethality did not require SMG6 in nonsense-mediated mRNA decay (NMD) but in regulating telomerase reverse transcriptase (TERT) activity. In addition, the RNA-dependent DNA polymerase (RdDP) activity of TERT was required for this synthetic lethal phenotype. We confirmed the inhibitory effects of LATS2 and SMG6 on cell proliferation in vivo. The result suggests an interaction between the Hippo and TERT signaling pathways. We also propose that SMG6 and TERT are novel molecular target candidates for LATS2-inactivated cancers such as MM.

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Death Discov Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Death Discov Año: 2022 Tipo del documento: Article País de afiliación: Japón